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http://dx.doi.org/10.1016/j.stemcr.2016.09.007SUMMARYPoly(A) tail length and mRNA deadenylation play important roles in gene regulation. However, how they regulate embryonic develop-
ment and pluripotent cell fate is not fully understood. Here we present evidence that CNOT3-dependent mRNA deadenylation governs
the pluripotent state. We show that CNOT3, a component of the Ccr4-Not deadenylase complex, is required for mouse epiblast mainte-
nance. It is highly expressed in blastocysts and its deletion leads to peri-implantation lethality. The epiblast cells in Cnot3 deletion
embryos are quickly lost during diapause and fail to outgrow in culture.Mechanistically, CNOT3C terminus is required for its interaction
with the complex and its function in embryonic stem cells (ESCs). Furthermore, Cnot3 deletion results in increases in the poly(A) tail
lengths, half-lives, and steady-state levels of differentiation gene mRNAs. The half-lives of CNOT3 target mRNAs are shorter in ESCs
and become longer during normal differentiation. Together, we propose that CNOT3 maintains the pluripotent state by promoting
differentiation gene mRNA deadenylation and degradation, and we identify poly(A) tail-length regulation as a post-transcriptional
mechanism that controls pluripotency.INTRODUCTION
Pluripotency is defined as the ability of a single cell to give
rise to all the cell types formedby the three germ layers (Pos-
fai et al., 2014). It is a unique property of the epiblast cells in
early embryos, and can also be captured in embryonic stem
cells (ESCs) in culture (Boroviak andNichols, 2014;Martello
and Smith, 2014). ESCs provide an invaluable platform
from which to investigate the molecular mechanisms that
regulate pluripotency. It has been shown that the pluripo-
tent state in ESCs is controlled by a combination of signal-
transduction pathways, transcription factors, epigenetic
modifiers, RNA binding proteins, and regulatory RNAmol-
ecules (Dejosez and Zwaka, 2012;Hackett and Surani, 2014;
Martello andSmith, 2014).Althoughextensive researchhas
focused on the signaling, transcriptional, and epigenetic
regulation in ESCs (Ng and Surani, 2011; Wang et al.,
2014; Young, 2011), how post-transcriptional mechanisms
can influence the ESC gene expression program and the
pluripotent state has only begun to be revealed. Indeed,
recent studies showed that post-transcriptional regulation,
such as alternative splicing (Gabut et al., 2011), alternative
polyadenylation (Lackford et al., 2014), RNA export (Wang
et al., 2013), and RNA modification (Geula et al., 2015),
plays critical roles in ESC maintenance and pluripotency
(Wright and Ciosk, 2013; Ye and Blelloch, 2014).
Most eukaryotic mRNAs are polyadenylated, and poly(A)
tail lengths are important for post-transcriptional geneThis is an open access article under the Cregulation (Eckmann et al., 2011; Norbury, 2013). It has
been shown that mRNA deadenylation is a main determi-
nant of mRNA poly(A) tail length, and can influence
mRNA half-life and/or translation efficiency in different
cellular contexts (Eckmann et al., 2011; Norbury, 2013). A
recent study showed that the poly(A) tail length appears
to have a more profound impact on mRNA stability than
mRNA translation in cells with active transcription (Sub-
telny et al., 2014).
To investigatewhether andhowmRNApoly(A) tail length
and deadenylation regulates embryonic development and
pluripotent cell fate, we focused on the Ccr4-Not complex.
Ccr4-Not is themainmRNAdeadenylase complex ineukary-
otic cells that shortensmRNApoly(A) tails (Collart and Pan-
asenko, 2012; Shirai et al., 2014; Xu et al., 2014). It has been
implicated in various physiological and developmental pro-
cesses, such as spermatogenesis (Berthet et al., 2004), heart
development (Neely et al., 2010), energy metabolism (Mor-
ita et al., 2011), B cell differentiation (Inoue et al., 2015),
osteoporosis (Watanabe et al., 2014), reprogramming (Ka-
mon et al., 2014), and ESC self-renewal (Hu et al., 2009;
Zheng et al., 2012). However, its role in early development
and the mechanism by which it regulates pluripotency
remain to be fully elucidated. In this study, we focus on
the CNOT3 subunit in the complex and present evidence
that the poly(A) tail-length regulation by CNOT3 serves as
a post-transcriptional regulatory mechanism governing
early development and ESC maintenance.Stem Cell Reports j Vol. 7 j 897–910 j November 8, 2016 j 897
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Cnot3 Is Required for Early Embryonic Development
(A and B) Cnot3 expression in pre-implantation embryos. Expression was determined by qRT-PCR and plotted as mean ± SEM from three
independent experiments (A) and immunofluorescence staining (B). Scale bar, 20 mm.
(C) Immunofluorescence staining of CNOT3 in WT and Cnot3 deletion embryos at the indicated developmental stages. Scale bars,
20 mm.
(D) Morphology of WT and Cnot3 deletion embryos at E6.5 and E7.5. Scale bars, 100 mm.
(E) Morphology and OCT4 expression of Cnot3 deletion embryo at E6.5. Scale bars, 20 mm.
(F) Numbers and genotypes of embryos collected at the indicated developmental stages. Numbers of morphologically abnormal embryos
are listed in parentheses.RESULTS
Cnot3 Expression Is Upregulated in the Blastocysts
The Ccr4-Not complex is themain deadenylase complex in
eukaryotic cells and regulates mRNA poly(A) tail length. To
test the roles of Ccr4-Not and mRNA poly(A) tail length in
mouse embryonic development, we focused on the Cnot3
subunit because its silencing resulted in prominent pheno-
typic and gene expression changes in ESCs (Zheng et al.,
2012). We first examined Cnot3 expression during pre-im-898 Stem Cell Reports j Vol. 7 j 897–910 j November 8, 2016plantation development. By qRT-PCR, we found thatCnot3
mRNA level is high in one-cell embryos, presumably from
maternal expression, and is elevated again in blastocysts
during pre-implantation development (Figure 1A). Immu-
nofluorescence staining showed that Cnot3 protein expres-
sion is in agreement with the above pattern (Figure 1B).
Furthermore, Cnot3 is enriched in the inner cell mass at
the blastocyst stage. It predominantly localizes in the cyto-
plasm (Figure 1B), consistent with the notion that it is a
part of the Ccr4-Not complex that regulates mRNAs.
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Figure 2. Cnot3 Deletion Impairs Epiblast Maintenance
(A) Immunofluorescence staining of epiblast markers OCT4, NANOG, and trophectoderm marker CDX2 in WT and Cnot3 deletion embryos.
Scale bars, 20 mm.
(B) Total cell number and percentage of OCT4-, NANOG-, or CDX2-positive cells in WT and Cnot3 deletion embryos. Values were plotted as
mean ± SEM from three independent experiments.
(C) Epiblast cell outgrowth from WT and Cnot3 deletion blastocysts. White arrows, epiblast cells; black arrows, trophectoderm cells. Scale
bars, 20 mm.Cnot3 Is Required for Epiblast Maintenance
To test its role in embryonic development, we generated a
Cnot3 conditional deletion mouse model by conventional
gene targeting (Figures S1A–S1D). We confirmed the suc-
cessful depletion of the Cnot3 protein in the null embryos
by immunofluorescence staining (Figure 1C). Because
Cnot3 is required for ESC maintenance, we hypothesized
that it may play important roles in the specification or
maintenance of the epiblast. Consistent with the hypothe-
sis, we found that Cnot3 deletion resulted in early embry-onic lethality, as we were not able to recover any viable
null pups or embryos with normal morphology at embry-
onic day 6.5 (E6.5) to E7.5 (Figures 1D–1F, S1F, and S2A).
At E3.5 and E4.5, Cnot3 deletion embryos appear normal
and were recovered at a Mendelian ratio (Figure 1F).
Furthermore, the expression pattern of the epiblast
(Nanog), trophectoderm (Cdx2), and primitive endoderm
markers (Gata4, Gata6, Pdgfra) was comparable between
the null and wild-type (WT) embryos (Figures 2A and
S2B). Thus, Cnot3 may not be required for the formationStem Cell Reports j Vol. 7 j 897–910 j November 8, 2016 899
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Figure 3. CNOT3 C-Terminal Domain Is Required for ESC Maintenance
(A) Domain structure of mouse CNOT3.
(B and C) Induction of Cnot3 deletion in Cnot3 cKO ESCs. Cells were treated with or without 4-OHT, and Cnot3 expression was determined
by qRT-PCR (B) and western blot (C) at the indicated time points. Values were plotted as mean ± SEM from three independent
experiments.
(D) Interaction between CNOT3 fragments and CNOT1 or CNOT2. HA-tagged CNOT3 fragments were expressed in Cnot3 cKO ESCs and affinity
purified by HA beads. Co-purified endogenous CNOT1 and CNOT2 were detected by western blot. Whole images of the same blots are shown
in Figure S4B.
(legend continued on next page)
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of the blastocysts and the specification of the epiblast line-
age, although we cannot rule out the possible contribution
from maternal expression (Figures 1A and 1B).
To further test the role ofCnot3 in themaintenance of the
epiblast, we used the embryonic diapause model. During
diapause, the embryos are arrested in utero at the late blas-
tocyst stage and the pluripotent state is maintained in
the epiblast cells for an extended period of time (Fenelon
et al., 2014). We found that Cnot3 was clearly required for
the maintenance of the blastocysts during diapause, as
the deletion embryos show significant compromise in
morphology and reduction in size (Figures 1F and 2A;
Movie S1). Quantitatively, Cnot3 deletion led to a decrease
in the total cell number in the embryos. More importantly,
it led to a reduction in the percentage of cells expressing
epiblast markers Oct4 and Nanog, but not those expressing
the trophectoderm marker Cdx2 (Figures 2A and 2B), sug-
gesting that epiblast cells were lost in the null embryos.
To further support these findings, we carried out epiblast
outgrowth studies. As expected, epiblast cells from Cnot3
null blastocysts failed to expand and grow into colonies,
while trophectodermcells continued to survive (Figure 2C).
Together, our data support the notion that Cnot3 is
required for the maintenance of the pluripotent epiblast
cells in vivo.
CNOT3 C-Terminal Domain Is Required for ESC
Maintenance
To understand how CNOT3 regulates the pluripotent state,
we carried out structure-function analysis to determine the
functional domain(s) in Cnot3. Based on sequence and
structural information, the Cnot3 protein can be divided
into theN-terminal,middle (NM), andC-terminal domains
(Figure 3A) (Boland et al., 2013). We generated Cnot3 con-
ditional knockout (cKO) ESCs in which Cnot3 mRNA and
protein can be quickly depleted upon tamoxifen treatment
(Figures S3A, 3B, and 3C). Cnot3 deletion led to ESC differ-
entiation as indicated by obvious changes in cellular
morphology and lineage marker expression (Figures S3B
and S3C). Importantly, its deletion induced upregulation
of differentiation genemarkers even in the 2i + LIFmedium
that supports the ground state (Figure S3D). However, it did
not induce obvious changes in caspase-3 cleavage (Figures
S3E and S3F), suggesting that CNOT3 does not directly
regulate apoptosis. In the Cnot3 cKO ESCs, we overex-
pressed CNOT3 full-length (FL), N-terminal and NM, and
C-terminal domains (Figure S4A). Consistent with previous(E–G) Rescue of the deletion phenotype by the overexpression of CNOT
treated with or without 4-OHT. Changes in cellular morphology (E; sc
were determined by imaging, qRT-PCR, and alkaline phosphatase staini
Actin and plotted as mean ± SEM from three independent experimenresults from other cell types (Boland et al., 2013), we found
that the C-terminal domain in CNOT3 is responsible for
its interaction with CNOT1 and CNOT2 in the Ccr4-Not
complex in ESCs (Figure 3D, and whole blot images in
S4B). More importantly, the overexpression of either the
CNOT3 full-length or C-terminal domain led to normal
morphology and marker expression after the depletion of
the endogenous CNOT3 by tamoxifen treatment (Figures
3E and 3F). Furthermore, the overexpression sustained
the formation of normal ESC colonies at clonal density
(Figures 3G and S4C). In contrast, overexpression of the
CNOT3 N-terminal and NM domains (Figure S4A) had no
effect (Figures 3E–3G), even though this fragment retained
the interaction with Cnot1 (Figure 3D). Therefore, our
results showed that the CNOT3 C-terminal domain is
required for the maintenance of the pluripotent state,
possibly via the interaction with CNOT1, CNOT2, and
other unknown factors.
CNOT3 Negatively Regulates Differentiation Gene
Expression
Because the Ccr4-Not complex regulates mRNA deadenyla-
tion, we hypothesize that CNOT3 may regulate the gene
expression program in pluripotent cells post-transcription-
ally. Indeed, immunofluorescence staining showed that
CNOT3 localizes predominantly in the cytosol in both
epiblast cells in vivo and ESCs in vitro (Figures 1B and
S5A). Moreover, CNOT3 remained in the cytosol in ESCs
even after nuclear export was blocked by leptomycin B
treatment. These results are consistent with the idea that
CNOT3 likely acts on mRNAs in the cytosol.
Gene expression analysis showed that Cnot3 deletion led
to the upregulation of 840 genes and downregulation of
436 genes at the mRNA level (Figure 4A and Table S1; fold
change >2, false discovery rate [FDR] <0.05). Gene ontology
(GO) analysis showed that genes upregulated after Cnot3
deletion are highly enriched for those that are involved
in normal differentiation and development (Figure 4B).
Together, these results support the notion that CNOT3 in-
hibits differentiation and development of gene expression.
CNOT3 Promotes mRNA Degradation
To determine its role in the gene expression program in
pluripotent cells, we first tested whether Cnot3 deletion
has an impact on mRNA translation. We carried out poly-
some fractionation (Sampath et al., 2011) in both control
and tamoxifen-treated Cnot3 cKO ESCs, and isolated3 domains. Cnot3 cKO ESCs expressing various CNOT3 fragments were
ale bars, 200 mm), marker expression (F), and colony formation (G)
ng, respectively. For qRT-PCR, relative expression was normalized by
ts.
Stem Cell Reports j Vol. 7 j 897–910 j November 8, 2016 901
02
4
6
8
10
12
D
ev
el
op
m
en
ta
l P
ro
ce
ss
Sy
st
em
 D
ev
el
op
m
en
t
O
rg
an
 D
ev
el
op
m
en
t
C
el
l D
iff
er
en
tia
tio
n
C
el
lu
la
r D
ev
el
op
m
en
t
Pl
ac
en
ta
 D
ev
el
op
m
en
t
H
ea
rt
 D
ev
el
op
m
en
t
Ti
ss
ue
 D
ev
el
op
m
en
t
-L
og
( p
-v
al
ue
)
B
p=3.9x10-12 p=0.936
Half-life up Half-life up
DEG 
up
DEG
down3210 3210
840
436
194 53
Cnot3 KO vs WT expression
-L
og
10
(p
-v
al
ue
)
Down
n=436
Up
n=840
-3       -2       -1        0        1        2        3 
0 
   
   
   
   
 5
0 
   
   
   
   
10
0 
   
   
   
  1
50
p=1.7x10-167WT
Cnot3 KO
mRNA half life (hour)
N
um
be
r o
f g
en
es
N
um
be
r o
f g
en
es
m
R
N
A 
ha
lf 
lif
e 
(h
ou
r)
W
T
C
no
t3
K
O
0 
   
  1
00
0 
  2
00
0 
41
00
0 
   
  1
00
0 
  2
00
0 
mRNA half life (hour)
0         5          10        15         20       24
0         5          10        15         20       24
5 
   
  1
0 
   
  1
5 
   
 2
0
D
Cnot3 KO–WT half life (hour)
D
en
si
ty
Down-regulated
Up-regulated
p=6.3x10-12
-10                0                10               20
0.
00
   
   
   
 0
.0
5 
   
   
   
0.
10
   
   
   
 0
.1
5 
   
   
  0
.2
0 
EC
A
Figure 4. Cnot3 Deletion Leads to Increases in mRNA Half-Life and Steady-State Level
(A) Gene expression changes after Cnot3 deletion in ESCs. Cnot3 cKO ESCs were treated with (KO) or without 4-OHT (WT). Cells were
collected 72 hr after treatment and total RNAs were prepared for RNA-seq.
(B) GO analysis of upregulated genes after Cnot3 deletion. Only selected GO categories were plotted. For complete list of enriched GO
categories, see Table S2.
(C and D) Increase in mRNA half-life in a subset of genes after Cnot3 deletion. Cnot3 cKO ESCs were treated with (KO) or without 4-OHT
(WT). Actinomycin D was added 48 hr after treatment, and cells were collected at 0, 4, and 8 hr after actinomycin D addition for RNA-seq.
(C) Frequency distribution and box plot for mRNA half-life in WT or KO samples. (D) Changes in mRNA half-life for genes down- or up-
regulated after Cnot3 deletion.
(E) Venn diagrams showing the overlaps between genes with extended mRNA half-lives and those that are down- or upregulated after Cnot3
deletion.polysome-associated RNAs. By RNA sequencing (RNA-seq),
we found that Cnot3 deletion resulted in very similar
changes in total RNAs versus polysome-associated RNAs
(Figure S5B), suggesting that Cnot3 deletion did not have
a significant impact on mRNA translation.902 Stem Cell Reports j Vol. 7 j 897–910 j November 8, 2016Next, we tested whether Cnot3 deletion affects mRNA
stability. We inhibited transcription in the control and
tamoxifen-treated Cnot3 cKO ESCs with actinomycin D,
and determined the decay rate of all transcripts by carrying
out RNA-seq at defined time points. We found that Cnot3
deletion led to an increase in mRNA half-life (Figure 4C).
Importantly, while the increase in half-life (fold change >2,
FDR <0.05; see Experimental Procedures for details) was
detected for many mRNAs that were upregulated after
Cnot3 deletion, there was little change in half-life for those
mRNAs that were downregulated (Figure 4D). Indeed, 194
mRNAs show increases inboth stability andexpression (Fig-
ure 4E, p<3.931012) afterCnot3deletion,whichare likely
direct targets of CNOT3. In contrast, there is no significant
overlap between mRNAs with extended half-life and those
with reducedexpression.Notably,CNOT3was recently sug-
gested to regulate cell death-inducing genes in mouse em-
bryonic fibroblasts (MEFs) (Suzuki et al., 2015). However,
CNOT3 does not appear to regulate such cell death-
inducing genes in ESCs, and there is no significant overlap
between the 194 CNOT3 target genes in ESCs and those
determined by similar methods in MEFs (Figure S5C).
Together, these results suggest that CNOT3 specifically pro-
motes the degradation of a subset of mRNAs in ESCs.
Cnot3-Dependent Differentiation Gene mRNA
Degradation Plays an Important Role in the
Maintenance of the Pluripotent State
Gene set enrichment analysis (GSEA) showed that the 194
CNOT3 target genes are highly enriched for those that are
upregulated during normal ESC differentiation (Figure 5A),
suggesting that CNOT3 promotes differentiation gene
mRNA degradation. To further test this idea, we compared
the gene expression changes caused byCnot3 deletion with
those caused by the depletion of pluripotency genes and
overexpression of differentiation genes in ESCs. Unsuper-
vised hierarchical clustering analysis revealed that the
pluripotency and differentiation genes clustered separately
and formed two distinct modules. Consistent with our
hypothesis, Cnot3 deletion clustered with the overexpres-
sion of differentiation genes (Figure 5B), including those
that are likely its direct targets such as Foxa1 and Sox9
(see below).
Intriguingly, the CNOT3 target genes showed shorter
half-life compared with pluripotency genes in ESCs (Fig-
ure 5C), and their half-lives were extended during normal
differentiation (Figure 5D). Indeed, the half-lives of differ-
entiation gene mRNAs in general are shorter in ESCs and
become longer during differentiation, while pluripotency
gene mRNAs do not show the same trend. These results
suggest that CNOT3-dependent regulation of differentia-
tion gene mRNA stability may play an important role in
themaintenance of the pluripotent state. Finally, we found
that the CNOT3 target genes tend to be bivalentlymodified
by H3K4me3 and H3K27me3 near their transcription start
sites (Figure 5E), suggesting that CNOT3 further dampens
the expression of poised developmental genes in pluripo-
tent cells at the post-transcriptional level.Cnot3 Promotes Differentiation Gene mRNA
Deadenylation
To test whether CNOT3 may regulate the poly(A) tail
length of its target mRNAs, we first examined global poly-
adenylation in WT and KO ESCs. We found that Cnot3
deletion led to a subtle increase in global polyadenylation
(Figure S5D), suggesting that only a subset of mRNAs
were affected. To further test the impact of Cnot3 deletion
on specific mRNAs, we fractionated total RNAs from con-
trol or tamoxifen-treated Cnot3 cKO ESCs based on poly(A)
tail length using oligo(dT) beads (Meijer and de Moor,
2011) (Figure 6A). To assess the fractionation efficiency,
we added in vitro synthesized mRNA standards with
defined poly(A) tail lengths (Figure S5E) to both WT and
KO total RNAs before the fractionation. By qRT-PCR, we
found that the added poly(A) tail standards were recovered
from the different fractions with expected efficiency, con-
firming the validity of the procedure (Figure 6B). Using
this method, we tested the impact of Cnot3 deletion on
poly(A) tails of several genes, including the housekeeping
gene Actin, the pluripotency genes Sox2,Oct4,Nanog, Esrrb,
Rex1, and the differentiation genes Cited1, Foxa1, Hand1,
and Sox9. We found that Cnot3 deletion led to an increase
inmRNApoly(A) tail length in differentiation genesCited1,
Foxa1, Hand1, and Sox9, without affecting the poly(A) tail
length of housekeeping or pluripotency genes (Figures 6C
and S5F). Interestingly, poly(A) tails appear to be longer
in pluripotency than differentiation gene mRNAs (Figures
6C and S5F), consistent with our finding that pluripotency
gene mRNAs tend to have longer half-lives (Figure 5C).
Consistent with the above data, qRT-PCR showed that
while Cnot3 deletion led to increases in the stability of
Hand1, Foxa1, Sox9, and Cited1 mRNAs, it had no impact
on the stability of Actin or Sox2 mRNAs (Figure 6D).
Furthermore, Cnot3 deletion led to an upregulation of the
steady-state level of the differentiation gene mRNAs, but
not that ofActin or Sox2 (Figure S3C). Aswe have previously
shown that CNOT1, CNOT2, and CNOT3 from the Ccr4-
Not complex are all required for ESC maintenance (Zheng
et al., 2012), we also tested the effect of Cnot1 and Cnot2
silencing on the half-life of the differentiation gene tran-
scripts. Unlike Cnot3 deletion, Cnot1 and Cnot2 silencing
by small interfering RNAs showed very little impact (Fig-
ure S5G), suggesting that Cnot3 may play a unique role in
post-transcriptional gene regulation in ESCs. This is consis-
tent with our previous finding thatCnot3 silencing resulted
in the most prominent phenotypic and gene expression
changes in ESCs (Zheng et al., 2012), and is also consistent
with the notion that individual subunits in the Ccr4-
Not complex may differentially regulate its function
(Azzouz et al., 2009). Finally, overexpression of Hand1,
Foxa1, Sox9, and Cited1 induced ESC differentiation based
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Figure 5. Cnot3 Deletion Impairs Differentiation Gene Degradation
(A) GSEA showing the enrichment for differentiation genes in the 194 CNOT3 target genes from Figure 2E.
(B) Hierarchical clustering analysis showing the similarity in gene expression profiles after depletion of pluripotency genes and
overexpression of differentiation genes (see Table S3 for gene expression datasets used in this plot).
(C) Box plot for the half-lives of CNOT3 target genes, pluripotency genes, differentiation genes, and all genes in ESCs.
(D) Box plot showing the changes in half-lives for CNOT3 target genes, pluripotency genes, differentiation genes, and all genes in ESCs
during differentiation.
(E) Metagene analysis and box plots (based on yellow highlighted regions in the metagene analysis) for H3K4me3 and H3K27me3
occupancy at the transcription start sites (TSS) of the CNOT3 target genes and all genes.
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together, we propose that CNOT3 promotes the deadenyla-
tion and degradation of the differentiation gene mRNAs to
maintain the gene expression program in pluripotent cells
(Figure 6E).DISCUSSION
In pluripotent cells, the delicate balance between self-
renewal and differentiation is tightly governed by a com-
plex gene expression program. While transcription may
function as an on-off switch to activate pluripotency genes
and repress differentiation genes, post-transcriptional
regulations can provide extra layers of control to refine
the transcriptional output. In this study, we show that
CNOT3, possibly via the Ccr4-Not complex,maintains plu-
ripotency by promoting the deadenylation and degrada-
tion of differentiation gene mRNAs. Our finding reveals a
previously uncharacterized mechanism in the mainte-
nance of pluripotency, and provides additional evidence
that post-transcriptional regulation is an integral part of
the pluripotency regulatory network.
The length of poly(A) tails plays an important role in con-
trolling mRNA degradation and translational silencing,
and is therefore dynamically regulated during develop-
ment and disease (Eckmann et al., 2011; Norbury, 2013).
A recent study showed that poly(A) tail length predomi-
nantly correlated with mRNA stability in transcriptionally
active cells. Furthermore it showed that, during embryonic
development, poly(A) tail length initially regulated transla-
tional efficiency and gradually shifted to regulate mRNA
stability as zygotic transcription started (Subtelny et al.,
2014). Our results are consistent with the above observa-
tions, and suggest that poly(A) tail-length regulation by
Ccr4-Not may start to affect mRNA stability as early as at
the blastocyst stage in mammals.
The Ccr4-Not complex is one of the main deadenylases
in mammalian cells that remove poly(A) tails. It can cata-
lyze deadenylation in both gene- and context-specificman-
ners to allow control of poly(A) tail lengths (Collart and
Panasenko, 2012; Shirai et al., 2014; Xu et al., 2014). It
has been proposed that different RNA binding proteins
and/or different subunits in the Ccr4-Not complex may
mediate the recruitment and regulation of different target
mRNAs. For example, in germ cell development, NANOS2
andNANOS3 can interact with different Ccr4-Not subunits
to regulate different mRNA targets (Suzuki et al., 2014). In
ESCs, PUM1 facilitates the exit from the pluripotent state
by binding to pluripotency gene mRNAs and promoting
their degradation (Leeb et al., 2014), presumably via the
interaction with CNOT7/8 in the Ccr4-Not complex (Van
Etten et al., 2012). Thus, we propose that there may exist
specific RNA binding proteins that facilitate the regulationof differentiation gene mRNAs by CNOT3 and Ccr4-Not in
pluripotent cells. This is consistent with the ‘‘RNA Regu-
lon’’ hypothesis, which suggests that mRNAs encoded by
functionally related genes may be coordinately regulated
by specific RNA processing machineries (Keene, 2007).
Along similar lines, it was recently reported that m6A
mRNA methylation reduces pluripotency gene mRNA sta-
bility to facilitate the exit from the pluripotent state in
ESCs and that m6A depletion led to post-implantation
lethality (Geula et al., 2015). Although it is not clear
whether Ccr4-Not is involved in the m6A-mediated
mRNA regulation, these and our results highlight the crit-
ical role of post-transcriptional regulation in the mainte-
nance of the pluripotent state both in vitro and in vivo.
Finally, we found that CNOT3 target gene mRNAs have
shorter half-lives in ESCs and acquire longer half-lives
during differentiation. This result suggested that mRNA
stability may indeed be a critical regulatory step, and that
CNOT3, as well as Ccr4-Not, plays an important role in
such a regulation to control pluripotent cell-fate specifica-
tion. In addition, we found that CNOT3 target genes
possess both active and repressive histone markers at their
promoters. Promoter regions with bivalent histone modifi-
cations were initially discovered in ESCs at developmental
genes, and were later shown to be present in epiblast cells
duringmouse development (Voigt et al., 2013). These biva-
lent genes are transcriptionally poised and can be activated
upon suitable developmental cues to facilitate the exit from
pluripotency. We propose that in addition to the transcrip-
tional repression, differentiation genes may be further
silenced by the Ccr4-Not complex at themRNA level. Regu-
lation of mRNA poly(A) tail length and stability may pro-
vide a quick and potentially reversible means to influence
differentiation gene expression. Thus, by controlling the
timely expression of differentiation genes, CNOT3 plays
an essential role in maintaining the responsiveness of
pluripotent cells to developmental signals.EXPERIMENTAL PROCEDURES
Antibodies
Mouse anti-CNOT3 (H00004849-M01, Abnova), goat anti-OCT3/4
(SC-8628, Santa Cruz Biotechnology), mouse anti-OCT3/4 (SC-
5279, Santa Cruz), rabbit anti-Cleaved Caspase-3 (ASP175, Cell
Signaling Technology), goat anti-GATA6 (AF1700, R&D Systems),
rat anti-PDGFRA (14-1401, eBioscience), goat anti-GATA4 (SC-
1237, Santa Cruz), rabbit anti-NANOG (RCAB002P-F, Cosmo
Bio), mouse anti-CDX2 (CDX-88, Biogenex) and mouse anti-
Cyclin B1 (AS4135, Cell Signaling).
Donkey anti-goat-493 (Nl003, R&D), donkey anti-mouse-594
(A21203, Life Technologies), donkey anti-rabbit-647 (A31573,
Life Technologies), goat anti-mouse-594 (A11005, Life Technolo-
gies), goat anti-mouse-488 (A11001, Life Technologies), goatStem Cell Reports j Vol. 7 j 897–910 j November 8, 2016 905
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anti-rabbit-488 (A11008, Life Technologies), goat anti-rabbit-594
(A11012, Life Technologies), goat anti-mouse-657 (A11078, Life
Technologies), rabbit anti-goat-488 (A11078, Life Technologies),
and goat anti-rat (A11006, Life Technologies).
Generation of Cnot3 Knockout Mice
Cnot3 conditional deletion (cKO) mice were generated by conven-
tional gene targeting (Figure S1A). The knockout construct was
generated by recombineering (Lee and Liu, 2009), linearized,
and electroporated into C2 ESCs (Gertsenstein et al., 2010).
Correctly targeted clones were verified by both genomic PCR
and Southern blot, and injected into C57BL/6 blastocysts. The re-
sulting chimeric mice were crossed with WT C57BL/6 mice to
derive the Cnot3tm1(LacZ)Hug F1 mice (Cnot3 LacZ/+). The F1
mice were further bred with Actb:FLPe mice, and backcrossed to
the C57BL/6 background to derive the Cnot3tm1.1(flox)Hug mice
(Cnot3 flox/+). The Cnot3 flox/+ mice were bred with the Zp3-
Cre transgenic mice to drive the Cnot3/+ mice. Cnot3 null em-
bryos were obtained by breeding the female Cnot3flox/+, Zp3cre
mice with the male Cnot3/+ mice. The genotypes of the animals
were determined by Southern blot, genomic PCR (see Table S2 for
primer sequences), or qRT-PCR by Transnetyx. All animal research
was conducted in accordance with the guidelines of the NIH An-
imal Care and Use Committee.
Mouse Embryo Collection and Immunofluorescence
Analyses
Pre-implantation embryos were flushed out from the oviducts or
uterus of pregnantmothers, and implanted E6.5 and E7.5 embryos
were surgical dissected from the uterus. Embryonic diapause was
induced in pregnant females 3 days aftermating by intraperitoneal
injection of Nolvadex (pharmaceutical grade tamoxifen, 10 mg in
100 mL of corn oil per mouse) and subcutaneous injection of
Depo Provera (pharmaceutical grade medroxyprogesterone, 1 mg
in 100 mL of corn oil permouse) (Buehr and Smith, 2003). Diapause
embryos were collected 3 days after the injections.
Embryos were fixed in 4% formaldehyde in PBS and immunoflu-
orescence staining was carried out using standard protocols for
whole embryos (Strumpf et al., 2005). Image data were acquired
with a Zeiss LSM 780 microscope. Optical sections of 5 mm thick-
ness were collected, and data processed by Imaris software. After
imaging, embryos were collected and genotyped by PCR (Ralston
et al., 2010).Figure 6. Cnot3 Deletion Increases Differentiation Gene mRNA P
(A) Schematic drawing for mRNA fractionation based on poly(A) tail
(B) Validation of the oligo(dT) fractionation method. Cnot3 cKO ESCs
standards were mixed with total RNAs extracted from the cells, and R
standard in each fraction (A0, A1, A2) was determined by qRT-PCR an
(C) Measurements of poly(A) tail length for the indicated genes by o
(D) Examination of mRNA stability for the indicated genes. Cnot3 c
Actinomycin D was added to the cells, and mRNA level was measured
were plotted as mean ± SEM from three independent experiments.
(E) Proposed model. CNOT3-dependent differentiation gene mRNA dea
of the pluripotent state.
*p < 0.05, **p < 0.01, ***p < 0.001; ns, non-significant.ESC Derivation and Culture
E14Tg2a (WT) and Cnot3 cKO ESCs (see below) were cultured in
gelatin-coated tissue culture plates in DMEM, 10% fetal bovine
serum, and 1,000 U/mL LIF, using standard procedures (Zheng
et al., 2012; Zheng andHu, 2012). For inhibition of nuclear export,
WT ESCs were treated with 10 nM leptomycin B for 4 hr. For mea-
surement of mRNA stability, WT ESCs were treated with 10 mg/mL
actinomycin D (Sigma, A-9415), and cells were harvested at 0, 4,
and 8 hr after the treatment.
The Cnot3 flox/+ mice were backcrossed into the 129 strain back-
ground and bredwith theUBC-Cre/ERT2 transgenicmice. Individ-
ual blastocyst embryo was plated, and the resulting ESC lines were
genotyped by PCR and Southern blot.Multiple Cnot3flox/flox, UBC-
Cre/ERT2 clones were established, and clone 8-4 was used for all
the experiments. To induceCnot3 deletion, we added 4-hydroxyta-
moxifen (4-OHT, Sigma) to the medium at 0.1 mM.
Cnot3 Domain Cloning and Expression
Mouse CNOT3 fragments corresponding to amino acids 1–751
(full length), 1–636 (NM), and 605–751 (C) were cloned from
into pDNR223, sequence verified, and transferred into a gateway
lentiviral expression vector PHAGE-EF1a-HA-Puro (Zheng et al.,
2012). They were used to package lentiviruses in 293T cells, and
the packaged viruses were used to transduce the Cnot3 cKO ESCs
to create stable expression clones. Expression of the exogenous
CNOT3 fragments was verified by qRT-PCR and western blot.
Two to three clones expressing the same fragment were tested
and behaved similarly in the rescue of the Cnot3 deletion pheno-
type, and the results from one clone were included in the figures.
Immunoprecipitation
Cnot3 cKO lines stably expressing hemagglutinin (HA)-tagged
CNOT3 domain fragments were lysed in 1% NP-40 buffer
(150 mM NaCl, 50 mM Tris [pH 8.0], 1% NP-40) with EDTA-free
protease inhibitors (Roche). Lysates were sonicated, centrifuged,
and pre-cleared with protein-A Sepharose beads. HA-tagged frag-
ments were immunoprecipitated with HA-affinity matrix (Roche),
and proteinwas elutedwith 23 lithiumdodecyl sulfate buffer with
2-mercaptoethanol and boiling. Proteins were resolved on 4%–
12% Bis-Tris gels (Life Technologies) and transferred to nitrocellu-
lose membranes. Western blots were conducted using an HA
antibody from Cell Signaling and Cnot1, Cnot2 antibodies from
Proteintech.oly(A) Tail Lengths
length.
were treated with (KO) or without 4-OHT (WT) for 48 hr. The poly(A)
NAs were fractionated by oligo(dT) beads. The distribution of each
d plotted as mean ± SEM from three independent experiments.
ligo(dT) fractionation.
KO ESCs were treated with (KO) or without 4-OHT (WT) for 48 hr.
by qRT-PCR at the indicated time points. Relative expression values
denylation and degradation plays a critical role in the maintenance
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Colony Formation Assay
Cnot3 cKO ESCs stably expressing Cnot3 domain fragments were
treated with 4-OHT at 0.1 mM for 48 hr. Cells were replated at 1,000
cells/cm2 in6-cmplates and allowed to grow for 7 days. The colonies
were stained for alkaline phosphatase activity (AP Staining II kit,
Stemgent). One hundred colonies were counted and scored as being
normal, partially differentiated, or fully differentiated based on
intensity of alkaline phosphatase staining and cellular morphology.
qRT-PCR and RNA-Seq
Total RNAs were extracted using the GeneJET RNA Purification Kit
(Thermo), and reverse transcribed using the iScript (Bio-Rad,
for qRT-PCRs) or the SuperScript II kit (Life Technologies, for
poly(A) tail-length determination). qPCRs were performed using
SsoAdvanced Universal SYBR Green Supermix (Bio-Rad) on CFX-
384 (Bio-Rad).
For RNA-seq, sequencing libraries were prepared using the
TruSeq RNA sample preparation kit v2 using the low sample proto-
col (Illumina). Sequencingwas performedon theMiSeq orNextSeq
sequencer (Illumina).
Polysome-Associated RNA Purification
Polysome-associated RNAs were purified as previously described
(Sampath et al., 2011). In brief, Cnot3 cKO ESCs were treated
with or without 4-OHT at 0.1 mM for 72 hr. Cytosolic proteins
were extracted and loaded onto linear sucrose gradients of 15%–
45% (w/w) and centrifuged for 2.5 hr at 30,000 rpm in an SW-41
rotor (Beckman). The gradients were fractionated into 0.4-mL frac-
tions on a Gradient Master (BioComp) and polysome fractions
were pooled. RNAs were extracted from both pooled polysome
fractions and total cell lysis and used for RNA-seq.
Poly(A) Tail-Length Analysis
DNA templates used for poly(A) tail-length standards were cloned
by PCR into the PCR-blunt II vector. Poly(A) tail-length standards
were generated by first synthesizing mRNAs from the DNA tem-
plates by in vitro transcription (RiboMax, Promega) and then add-
ingpoly(A) tails using thepoly(A) polymerase tailing kit (Epicenter)
with different reaction times. Products from the poly(A) tailing re-
actions were purified by denaturing PAGE and analyzed on Agi-
lent’s Bioanalyzer to determine the poly(A) tail lengths.
Separation ofmRNAs based on poly(A) tail lengthwas performed
based on a published protocol (Meijer and de Moor, 2011) with
modifications. In brief, 1 mg of total RNA was first mixed with
spike-in standards and then incubated with Oligo-dT Dynabeads
(Life Technologies) at room temperature for 10 min. The superna-
tant (the A0 fraction) was kept, and the elution solution was added
to the beads. The elution was carried out at 25C for the A1
fraction, and then again at 75C for the A2 fraction. RNAs in
each fraction were ethanol precipitated, and reverse transcribed
with the SuperScript II kit using random primers (Life Technolo-
gies). The percentage of individual transcript in each fraction rela-
tive to that in 1 mg of total RNA was determined by qRT-PCR.
Bioinformatics Analysis
Sequenced reads were aligned to the mouse genome (mm9) us-
ing the latest version of STAR (Dobin et al., 2013) by allowing908 Stem Cell Reports j Vol. 7 j 897–910 j November 8, 2016a maximum of three mismatches and retaining only unique
alignments. Gene expression raw counts were quantified by
counting aligned reads using the htseq-count program (Anders
et al., 2015) with Ensembl gene annotations. Raw gene counts
were subsequently normalized using the DESeq2 R package
(Love et al., 2014) for each replicate of the WT and Cnot3 KO
comparison experiment; and for each time point (0 hr, 4 hr,
and 8 hr) and each replicate of the WT and Cnot3 KO half-life
experiment. For the WT and Cnot3 KO comparison experiment,
normalized gene counts were used to identify differentially ex-
pressed genes using DESeq2. Genes with an FDR smaller than
0.05 and a fold change greater than 2 were deemed as differen-
tially expressed.
For RNA half-life estimation, genes that have fewer than six
normalized read counts at all three time points (0, 4, and 8 hr)
in either WT or Cnot3 KO were deemed as lowly expressed
and were removed. For genes that passed the filtering, their
half-lives were estimated as described in Sharova et al. (2009).
First, since the same amount of each sample was sequenced
for each time point, gene expression at 4 hr and 8 hr was cor-
rected by timing a scaling factor to account for relative increase
of stable mRNA due to the degradation of unstable species
after block of transcription. Then a linear regression of the
form y = a  bt was performed on each gene through the three
time points, where y is the log-transformed (base 10) read count,
t is the time, b is the slope, a is intercept, and d = b 3 ln(10) is
the instantaneous decay rate. Half-life of each gene was esti-
mated and projected as H = min(24, ln(2)/d) for positive d and
h = 24 hr for negative d. Genes that displayed significant differ-
ence of half-life in WT and Cnot3 KO were determined by
requiring a fold change greater than 2 and an FDR smaller
than 0.05, calculated as z= ðd1  d2Þ= ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃs1 + s2p , where d1 and d2
are decay rates estimated from regression for WT and Cnot3
KO, respectively, and s1 and s2 are standard errors of the esti-
mated decay rates.
Fisher’s exact test was performed on overlap of gene sets that
were significant in the half-life experiment and in the differen-
tial expression experiment, and on overlap of gene sets that
are significant in WT versus Cnot3 KO in ESCs and MEFs (Suzuki
et al., 2015). GSEA was performed to test for enrichment of
gene set against EB differentiation data at day 9 (Hailesellasse
Sene et al., 2007). Hierarchical clustering was performed
to generate the heatmap profile and clustering global expres-
sion change after knockout, knockdown, or overexpression of
each given gene (Correa-Cerro et al., 2011; Zheng et al., 2012).
ESC-associated genes and differentiation-associated genes were
defined by taking the top 5% and the bottom 5% of the genes
ranked in Cinghu et al. (2014). Tag densities of H3K4me3
and H3K27me3 were generated by aligning H3K4me3 (Agarwal
and Jothi, 2012) and H3K27me3 (Ho et al., 2011) sequencing
data to mm9 genome using Bowtie (Langmead et al.,
2009) by allowing two mismatches and retaining only unique
alignment.
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